Mesalazine
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Gastrointestinal & Digestion treatment.
🧴 Clinical Application
Take orally with meals with a full glass of water. Active flare: 2.4 g to 4.8 g daily in divided doses (or 2.4 g to 4.8 g once daily with MMX formulations). Remission maintenance: 1.2 g to 2.4 g once daily. Swallow tablets whole; do NOT crush, split, or chew the specialized coating.
⚠️ Side Effects
Common: Headache, nausea, diarrhea, abdominal pain, flatulence, dyspepsia, rash. Rare/Severe: Acute intolerance syndrome (cramping, bloody diarrhea mimicking UC flare), interstitial nephritis and renal impairment, pancreatitis, and pericarditis/myocarditis.
🛡️ Safety Warnings
Monitor renal function (serum creatinine, urinalysis) prior to therapy, every 3 months for the first year, and annually thereafter. Contraindicated in severe renal or hepatic impairment and salicylate hypersensitivity. If paradoxical bloody diarrhea occurs, discontinue immediately.
Jan Aushadhi Products containing Mesalazine
Found 4 generic formulation(s) containing this active ingredient.
Mesalazine Prolonged release Tablets 1200 mg
Mesalazine / Mesalamine (400mg, 500mg, 800mg, 1200mg Delayed Release / Prolonged Release Tablets) is an oral 5-aminosalicylic acid (5-ASA) anti-inflammatory agent on the WHO Model List of Essential Medicines. Formulated with pH-dependent (pH >= 7) enteric coatings or multi-matrix (MMX) core systems to bypass gastric degradation and deliver high local 5-ASA concentrations specifically to the terminal ileum and colon. Locally inhibits 5-lipoxygenase, reduces leukotriene B4 and pro-inflammatory prostaglandin synthesis, and scavenges free radicals without systemic corticosteroid toxicity. Indicated for induction and maintenance of clinical and endoscopic remission in mild-to-moderate ulcerative colitis.
Mesalazine Prolonged release Tablets 500mg
Mesalazine / Mesalamine (400mg, 500mg, 800mg, 1200mg Delayed Release / Prolonged Release Tablets) is an oral 5-aminosalicylic acid (5-ASA) anti-inflammatory agent on the WHO Model List of Essential Medicines. Formulated with pH-dependent (pH >= 7) enteric coatings or multi-matrix (MMX) core systems to bypass gastric degradation and deliver high local 5-ASA concentrations specifically to the terminal ileum and colon. Locally inhibits 5-lipoxygenase, reduces leukotriene B4 and pro-inflammatory prostaglandin synthesis, and scavenges free radicals without systemic corticosteroid toxicity. Indicated for induction and maintenance of clinical and endoscopic remission in mild-to-moderate ulcerative colitis.
Mesalazine Delayed release Tablets 800 mg
Mesalazine / Mesalamine (400mg, 500mg, 800mg, 1200mg Delayed Release / Prolonged Release Tablets) is an oral 5-aminosalicylic acid (5-ASA) anti-inflammatory agent on the WHO Model List of Essential Medicines. Formulated with pH-dependent (pH >= 7) enteric coatings or multi-matrix (MMX) core systems to bypass gastric degradation and deliver high local 5-ASA concentrations specifically to the terminal ileum and colon. Locally inhibits 5-lipoxygenase, reduces leukotriene B4 and pro-inflammatory prostaglandin synthesis, and scavenges free radicals without systemic corticosteroid toxicity. Indicated for induction and maintenance of clinical and endoscopic remission in mild-to-moderate ulcerative colitis.
Mesalamine Delayed Release Tablets 400mg
Mesalazine / Mesalamine (400mg, 500mg, 800mg, 1200mg Delayed Release / Prolonged Release Tablets) is an oral 5-aminosalicylic acid (5-ASA) anti-inflammatory agent on the WHO Model List of Essential Medicines. Formulated with pH-dependent (pH >= 7) enteric coatings or multi-matrix (MMX) core systems to bypass gastric degradation and deliver high local 5-ASA concentrations specifically to the terminal ileum and colon. Locally inhibits 5-lipoxygenase, reduces leukotriene B4 and pro-inflammatory prostaglandin synthesis, and scavenges free radicals without systemic corticosteroid toxicity. Indicated for induction and maintenance of clinical and endoscopic remission in mild-to-moderate ulcerative colitis.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Mesalazine.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Mesalazine Prolonged release Tablets 1200 mg | 10's | ₹129.38 | MESINTA, MESAFLEX, MESANT | ₹1094.87 | 88% Save |
| Mesalazine Prolonged release Tablets 500mg | 10's | ₹70.31 | PENTASA, MESALMILE | ₹244.41 | 71% Save |
| Mesalazine Delayed release Tablets 800 mg | 10's | ₹91.41 | MESACOL, MESAHENZ, MESAZED | ₹123.38 | 26% Save |
| Mesalamine Delayed Release Tablets 400mg | 10's | ₹37.50 | MESACOL, MESAHENZ, MESALMILE | ₹77.15 | 51% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Mesalazine generics.